Mayo Clinic-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2021

  1. Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

    European Journal of Cancer, Vol. 152, pp. 68-77

2011

  1. p16 INK4a expression and breast cancer risk in women with atypical hyperplasia

    Cancer Prevention Research, Vol. 4, Núm. 12, pp. 1953-1960

2010

  1. Diagnostic utility of snail in metaplastic breast carcinoma

    Diagnostic Pathology, Vol. 5, Núm. 1

2009

  1. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

    Cancer Research, Vol. 69, Núm. 7, pp. 2887-2895

2008

  1. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer

    Journal of the National Cancer Institute, Vol. 100, Núm. 6, pp. 421-427